chr1-67168175-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144701.3(IL23R):c.55A>G(p.Ser19Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000087 in 1,608,988 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_144701.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IL23R | NM_144701.3 | c.55A>G | p.Ser19Gly | missense_variant | 2/11 | ENST00000347310.10 | |
IL23R | XM_011540790.4 | c.55A>G | p.Ser19Gly | missense_variant | 2/11 | ||
IL23R | XM_011540791.4 | c.55A>G | p.Ser19Gly | missense_variant | 2/11 | ||
IL23R | XM_047447227.1 | c.55A>G | p.Ser19Gly | missense_variant | 2/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IL23R | ENST00000347310.10 | c.55A>G | p.Ser19Gly | missense_variant | 2/11 | 1 | NM_144701.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000637 AC: 16AN: 251226Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135762
GnomAD4 exome AF: 0.00000892 AC: 13AN: 1456722Hom.: 0 Cov.: 29 AF XY: 0.0000110 AC XY: 8AN XY: 725022
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152266Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74456
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2023 | The c.55A>G (p.S19G) alteration is located in exon 2 (coding exon 1) of the IL23R gene. This alteration results from a A to G substitution at nucleotide position 55, causing the serine (S) at amino acid position 19 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 02, 2024 | This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 19 of the IL23R protein (p.Ser19Gly). This variant is present in population databases (rs185697788, gnomAD 0.08%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with IL23R-related conditions. ClinVar contains an entry for this variant (Variation ID: 1404883). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at